Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
British Journal of Clinical Pharmacology|July 1, 1993
The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasiasM D Tingle, B K ParkBritish Journal of Clinical Pharmacology|May 1, 1990
Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolitesM D Tingle, B K ParkEnvironmental Toxicology and Pharmacology|July 26, 2011
Can in vitro drug metabolism studies with human tissue replace in vivo animal studies?M D Tingle, N A HelsbyDiseases of Aquatic Organisms|May 27, 2006
Bioavailability and pharmacokinetics of a praziquantel bolus in kingfish Seriola lalandiL A Tubbs, M D TingleThe New Zealand Medical Journal|October 24, 2009
In vivo interactions between BZP and TFMPP (party pill drugs)Ushtana Antia, Malcolm D Tingle, Bruce R RussellThe New Zealand Medical Journal|February 12, 2010
'Party pill' drugs--BZP and TFMPPUstana Antia, Malcolm D Tingle, Bruce R RussellThe Journal of Laryngology and Otology|October 8, 2019
Measuring antibiotic levels and their relationship with the microbiome in chronic rhinosinusitisJ Siu, M D Tingle, R G DouglasThe Journal of Pharmacology and Experimental Therapeutics|March 24, 2011
Glucuronidation of anticancer prodrug PR-104A: species differences, identification of human UDP-glucuronosyltransferases, and implications for therapyYongchuan Gu, Malcolm D Tingle, William R WilsonThe Journal of Pharmacy and Pharmacology|July 11, 2009
Metabolic interactions with piperazine-based 'party pill' drugsUshtana Antia, Malcolm D Tingle, Bruce R RussellJournal of Forensic Sciences|June 11, 2010
Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humansUshtana Antia, Malcolm D Tingle, Bruce R RussellPageof 9